semaglutide loss of exclusivity Ozempic's patent problem: how Novo Nordisk lost control a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Generic Ozempic drugs are about

Consumers may start with Lane 1 changes, then graduate to Lane 2 supplements if they need an extra push, and only consider Lane 3 drugs if those dont suffice

Consumer expenditure on skincare and cosmetics, influenced by rising living standards, increasing disposable incomes, and the growing number of working women in the workforce, primarily drives glutathione consumption

Biochemistry 32, 46934697

It slows food movement through the digestive tract, making the person feel fuller for longer, helping the liver regulate sugar production, and reducing food cravings

GLP-1/GIP Clinical Trial Weight Loss Results Across multiple trials, GLP-1/GIP injections consistently led to substantial weight reduction, in the range of 15-26% depending on the dosage and trial conditions